Freya Biosciences secures new investment to develop microbial immunotherapies for bacterial vaginosis

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women’s health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates Foundation (the foundation) with $1.4 million additional financing from current investor Export and Investment Fund of Denmark (EIFO).

Patient-Centered Treatment in Generalized Myasthenia Gravis

Management of generalized myasthenia gravis (gMG) is beginning to address aspects of the autoimmune condition patients care about, including treatment tolerability and fatigue. Conventional treatments

December 6, 2023

Quest launches consumer test to assess Alzheimer’s risk

Dive Brief: Quest Diagnostics launched a consumer-facing version of its AD-Detect test to assess Alzheimer’s disease risk. The test, which costs $399, assesses levels of

August 1, 2023

Why Do We Encounter DMT Jesters and How to Understand Them

N-N-Dimethyltryptamine, also known as “The Spirit Molecule” or “the businessman trip” is one of the most mysterious and mind-bending psychedelics. The experiences DMT induces are

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.